Not all progestins are created equal — and the differences matter clinically. In this evidence-based session, Dr. Tami S. Rowen cuts through decades of conflation between synthetic progestins and bioidentical progesterone, providing clinicians with a practical framework for navigating today's expanding progestogen landscape. Drawing on the latest research in menopause management, sexual health, and gynecologic care for women with complex medical conditions, Dr. Rowen explores how progestogen selection impacts patient outcomes — from mood and libido to cardiovascular risk and endometrial protection. Whether you're managing menopausal hormone therapy, addressing sexual dysfunction, or caring for patients with chronic illness or cancer history, this session will sharpen your prescribing confidence and challenge assumptions you didn't know you had.

Tami S. Rowen, MD, MS, is a board-certified OB/GYN and Associate Professor at UCSF, specializing in sexual medicine, menopause, and gynecologic care for women with complex medical conditions. With dual training in OB/GYN and a Master’s in Global Health, Dr. Rowen is nationally recognized for her work at the intersection of sexual health, chronic illness, and cultural competency in care delivery.

At UCSF, she provides compassionate, evidence-based care for women with concerns related to sexual dysfunction, vulvovaginal disorders, menopause, and reproductive health in the setting of cancer, disability, or chronic disease. She is also an active researcher and educator, with a focus on improving sexual health access and outcomes for diverse populations.